Sterling completes site acquisition
Submitted by:
Andrew Warmington
UK-based CDMO Sterling Pharma Solutions has completed the acquisition of Novartis’ API facility in Ringaskiddy
Granules in green API project
Submitted by:
Andrew Warmington
Granules India and Greenko ZeroC have formed a strategic partnership to promote ‘integrated green pharmaceutical
Brenntag ends Univar merger discussions
Submitted by:
Andrew Warmington
Univar Solutions has confirmed that Brenntag has ended discussions with it about a potential merger
Kao, Firmenich lead in carbon disclosure
Submitted by:
Andrew Warmington
Non-profit organisation CDP (formerly the Carbon Disclosure Project) has issued its rankings for 2022. These
Merck completes M Chemicals buy
Submitted by:
Andrew Warmington
Merck KGaA has closed its previously announced details to acquire M Chemicals, the company recently
Evonik exits TAA derivatives
Submitted by:
Andrew Warmington
Evonik has completed the previously announced sale of its TAA derivatives business from its Specialty
Vertical life science campus planned for London
Submitted by:
Andrew Warmington
Canary Wharf Group and Kadans Science Partner have submitted a detailed planning application for a
Double expansion for Brenntag in South America
Submitted by:
Andrew Warmington
Brenntag has opened a new 90,000 m2 facility in Zarate, Argentina, and simultaneously presented
Rogue employees: The insider menace
Submitted by:
Andrew Warmington
Dr Dexter Morse, global head of insurance and risk at Arxada, looks at how
Feature article – The Midas touch
Submitted by:
Andrew Warmington
Midas Pharma is diversifying into new areas based on its longstanding non-GMP capabilities. We spoke